Financhill
Back

Quantum BioPharma Quote, Financials, Valuation and Earnings

Quantum BioPharma Price Quote

$4.13
+0.07 (+-1.9%)
(Updated: December 14, 2024 at 5:49 AM ET)

Quantum BioPharma Key Stats

Sell
39
Quantum BioPharma (QNTM) is a Sell

Day range:
$4.05 - $4.50
52-week range:
$3.50 - $70.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.5%

Volume:
51.2K
Avg. volume:
63.9K
1-year change:
-93.75%
Market cap:
$8.1M
Revenue:
$0
EPS:
$-15.47

How Much Does Quantum BioPharma Make?

Data Unavailable

Is Quantum BioPharma Growing As A Company?

Data Unavailable

Quantum BioPharma Stock Price Performance

  • Did Quantum BioPharma Stock Go Up Last Month?
    Quantum BioPharma share price went down by -23.25% last month
  • Did QNTM's Share Price Rise Over The Last Year?
    QNTM share price fell by -93.75% over the past 1 year

What Is Quantum BioPharma 52-Week High & Low?

Quantum BioPharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Quantum BioPharma?

  • How Much Debt Does Quantum BioPharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Quantum BioPharma Have?
    Cash and short term investments quarterly total is $6.6M
  • What Is Quantum BioPharma’s Book Value Per Share?
    Book value per share is 8.74

Is Quantum BioPharma Cash Flow Positive?

  • What Is QNTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.9M
  • What Is Quantum BioPharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.1M
  • What Is Quantum BioPharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.7M

Quantum BioPharma Return On Invested Capital

Data Unavailable

Quantum BioPharma Earnings Date & Stock Price

Quantum BioPharma Competitors

  • Who Are Quantum BioPharma's Competitors?
    Below is a list of companies who compete with Quantum BioPharma or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • ESSA Pharma Inc (EPIX)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

Quantum BioPharma Dividend Yield

Quantum BioPharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 84.27%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 680.78
Upside from Last Price: 16667.97%

Major Shareholders

  • How many QNTM shares are owned by institutional investors?
    573.3K QNTM shares are owned by institutional investors
  • How many QNTM shares are owned by insiders?
    0 QNTM shares are owned by insiders